Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.22.2.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 91,767 $ 7,174,854 $ 164,022,957 $ (154,444,983) $ 16,844,595
Beginning balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Compensation expense relating to option issuances 1,123,761 1,123,761
Net loss (5,219,945) (5,219,945)
Series C dividend $ 1,117,531 (1,117,531)
Series C dividend, shares   33.016      
Series C redemption   $ (5,635,672)     (5,635,672)
Series C Redemption, shares   (166.499)      
ATM offering - net of expenses $ 21,399 26,654,993 26,676,392
ATM offering - net of expenses, shares 21,398,765        
Issuance of common stock from warrant exercise $ 2,472 2,258,864 2,261,336
Issuance of common stock from warrant exercise, shares 2,472,573        
Ending balance, value at Mar. 31, 2021 $ 115,638 $ 2,656,713 194,060,575 (160,782,459) 36,050,467
Ending balance, shares at Mar. 31, 2021 115,638,266 16,017,000      
Beginning balance, value at Dec. 31, 2020 $ 91,767 $ 7,174,854 164,022,957 (154,444,983) 16,844,595
Beginning balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Net loss         (13,419,038)
Ending balance, value at Sep. 30, 2021 $ 116,395 $ 2,656,713 194,754,867 (168,981,552) 28,546,423
Ending balance, shares at Sep. 30, 2021 116,394,806 16,017,000      
Beginning balance, value at Mar. 31, 2021 $ 115,638 $ 2,656,713 194,060,575 (160,782,459) 36,050,467
Beginning balance, shares at Mar. 31, 2021 115,638,266 16,017,000      
Compensation expense relating to option issuances 231,140 231,140
Net loss (3,815,347) (3,815,347)
Issuance of common stock from option exercise $ 557 266,583 267,140
Issuance of common stock from option exercise, shares 556,540        
Ending balance, value at Jun. 30, 2021 $ 116,195 $ 2,656,713 194,558,298 (164,597,806) 32,733,400
Ending balance, shares at Jun. 30, 2021 116,194,806 16,017,000      
Compensation expense relating to option issuances     100,769   100,769
Net loss     (4,383,746) (4,383,746)
Issuance of common stock from option exercise $ 200   95,800   96,000
Issuance of common stock from option exercise, shares 200,000        
Ending balance, value at Sep. 30, 2021 $ 116,395 $ 2,656,713 194,754,867 (168,981,552) 28,546,423
Ending balance, shares at Sep. 30, 2021 116,394,806 16,017,000      
Beginning balance, value at Dec. 31, 2021 $ 116,395 $ 2,656,713 194,987,219 (171,274,128) 26,486,199
Beginning balance, shares at Dec. 31, 2021 116,394,806 16,017,000.000      
Compensation expense relating to option issuances 90,247 90,247
Net loss (6,035,394) (6,035,394)
Ending balance, value at Mar. 31, 2022 $ 116,395 $ 2,656,713 195,077,466 (177,309,522) 20,541,052
Ending balance, shares at Mar. 31, 2022 116,394,806 16,017,000.000      
Beginning balance, value at Dec. 31, 2021 $ 116,395 $ 2,656,713 194,987,219 (171,274,128) 26,486,199
Beginning balance, shares at Dec. 31, 2021 116,394,806 16,017,000.000      
Net loss         $ (13,985,730)
Issuance of common stock from option exercise, shares        
Ending balance, value at Sep. 30, 2022 $ 117,305 $ 1,592,723 196,888,079 (185,259,858) $ 13,338,249
Ending balance, shares at Sep. 30, 2022 117,304,809 9,467,000.000      
Beginning balance, value at Mar. 31, 2022 $ 116,395 $ 2,656,713 195,077,466 (177,309,522) 20,541,052
Beginning balance, shares at Mar. 31, 2022 116,394,806 16,017,000.000      
Compensation expense relating to option issuances 278,988 278,988
Net loss (4,032,693) (4,032,693)
Ending balance, value at Jun. 30, 2022 $ 116,395 $ 2,656,713 195,356,454 (181,342,215) 16,787,347
Ending balance, shares at Jun. 30, 2022 116,394,806 16,017,000.000      
Compensation expense relating to option issuances 468,545 468,545
Net loss (3,917,643) (3,917,643)
Conversion of Series A preferred stock to common stock $ 400 $ (415,169) 414,769
Conversion of Series A preferred stock to common stock, shares 400,001 (4,000,000)      
Conversion of Series B preferred stock to common stock $ 510 $ (648,821) 648,311
Conversion of Series B preferred stock to common stock, shares 510,002 (2,550,000)      
Ending balance, value at Sep. 30, 2022 $ 117,305 $ 1,592,723 $ 196,888,079 $ (185,259,858) $ 13,338,249
Ending balance, shares at Sep. 30, 2022 117,304,809 9,467,000.000